Sign In
Buy QGEN
$41.40
-0.0500 (-0.121%)
At Close: Jul 31, 2026
QIAGEN N.V. to Release Results for Q3 2022 and Hold Webcast
06:54am, Friday, 21'st Oct 2022
VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V.
Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks Unlikely
12:04pm, Tuesday, 11'th Oct 2022
A rumored matchup between Bio-Rad Laboratories and Qiagen is unlikely, an analyst said Tuesday as BIO stock fell for a second straight day. The post Why Bio-Rad Laboratories' Rumored $10 Billion Qiage
Bio-Rad and German-based biotech Qiagen weighing latest tie-up in medical-diagnostic market
08:56pm, Monday, 10'th Oct 2022
Bio-Rad Laboratories Inc. is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth more than $10 billion, according to people familiar with the matter.
Bio-Rad Laboratories in Talks to Combine With Qiagen
02:03pm, Monday, 10'th Oct 2022
Bio-Rad Laboratories Inc. is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth more than $10 billion, according to people familiar with the matter.
Here's Why You Should Retain QIAGEN (QGEN) Stock for Now
08:19pm, Thursday, 22'nd Sep 2022
Investors are optimistic about QIAGEN's (QGEN) better-than-expected results and solid genomics uptake.
QIAGEN (QGEN) Assays to Detect Organ Transplant-Related Viruses
01:32pm, Monday, 19'th Sep 2022
QIAGEN's (QGEN) latest additions to the NeuMoDx assay menu will help identify EBV and HHV-6 viruses in immunocompromised patients.
QIAGEN (QGEN) to Develop Companion Diagnostic for Neuron23
01:34pm, Thursday, 15'th Sep 2022
QIAGEN's (QGEN) novel companion diagnostic assay will help identify individuals who might benefit from Neuron23's drug candidate for Parkinson's disease.
QIAGEN's (QGEN) New Syndromic Test to Combat Monkeypox Spread
03:48pm, Friday, 19'th Aug 2022
QIAGEN (QGEN) joins the global fight against monkeypox with the launch of its novel QIAstat-Dx Viral Vesicular Panel RUO.
Qiagen NV (QGEN) CEO Thierry Bernard on Q2 2022 Results - Earnings Call Transcript
12:43am, Friday, 29'th Jul 2022
Qiagen NV (NYSE:QGEN ) Q2 2022 Earnings Conference Call July 28, 2022 9:30 AM ET Company Participants John Gilardi - VP, Corporate Communications & IR Thierry Bernard - CEO Roland Sacker - CFO Confere
QIAGEN (QGEN) Q2 Earnings Top Estimates, Margins Decline
02:50pm, Thursday, 28'th Jul 2022
QIAGEN (QGEN) posts better-than-expected results for the second quarter and raises its sales and earnings outlook for 2022 amid the uncertain macroeconomic environment.
Qiagen (QGEN) Beats Q2 Earnings and Revenue Estimates
05:53pm, Tuesday, 26'th Jul 2022
Qiagen (QGEN) delivered earnings and revenue surprises of 13.33% and 3.50%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
QIAGEN (QGEN) QCI's Robust Adoption to Enhance Patient Outcome
12:25pm, Wednesday, 20'th Jul 2022
QIAGEN's (QGEN) QCI platform is expected to significantly streamline NGS data analysis and variant interpretation, and enable swift and confident shift by users from raw NGS data to clinical report.
QIAGEN N.V. to Release Results for Q2 2022 and Hold Webcast
06:00am, Thursday, 07'th Jul 2022
VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. to release results for Q2 2022 and hold Webcast
QIAGEN CEO details how company tracks the spread of COVID through wastewater testing
12:00am, Saturday, 11'th Jun 2022
This segment originally aired on June 6, 2022. QIAGEN CEO Thierry Bernard joins Yahoo Finance Live anchors Brian Cheung and Akiko Fujita to explain how his company is utilizing technology to track the
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Up 2.8% Since Last Earnings Report: Can It Continue?
03:30pm, Thursday, 09'th Jun 2022 Zacks Investment Research
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
